glp-1 arizona study committee adopts recommendations to treat obesity as chronic disease, eyes advisory council; officials flag costs GLP-1 Drug Savings: A Complete

administered drug has been found safe and efficacious and is approved for the treatment of ITP in Japan [249,250,251]

The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157.5 billion by 2035, at a CAGR of 11.1% during the forecast period, till 2035

Brain Res Protocol 1:203209 Al-Roujayee A (2017) Improvement of sexual behavior, sperm quantity and quality by quercetin in streptozotocin-induced diabetic erectile dysfunction

Integrating these insights into personalized approaches can optimize injury prevention and recovery, ultimately improving the health and safety of individuals engaged in physical activities